Peak Human is pleased to announce that the first patients enrolled Plasmapheresis to Canada in March 2022 as part of a clinical trial examining the anti-aging effects of this cutting-edge procedure.
According to Dr. Sanjeev Goel, medical director at Peak Human, “Studies of the science behind the use of Plasmapheresis shows very promising results for rejuvenation and increased vitality of the body. Anecdoctal reports have shown that patients have a lower biologic age after the treatments. Many patients report increased energy, increased strength and greater immune function. We will be examining the impact of plasmapheresis treatments regularly over 2 years on longevity biomarkers.”
For patients interested in learning more https://peakhuman.activehosted.com/f/49
